|
The obesity paradigm on outcome in heart failure with reduced ejection fraction.
|
Eur Heart J
38240033
|
0 |
39.3 |
2024 |
|
Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper.
|
Europace
38291925
|
0 |
6.1 |
2024 |
|
Sodium-glucose cotransporter-2 inhibitors in heart failure patients across the range of body mass index: a systematic review and meta-analysis of randomized controlled trials.
|
Intern Emerg Med
38353880
|
0 |
4.6 |
2024 |
|
Increased Expression of Proinflammatory Genes in Peripheral Blood Cells Is Associated with Cardiac Cachexia in Patients with Heart Failure with Reduced Ejection Fraction.
|
J Clin Med
38337428
|
0 |
0 |
2024 |
|
2023 ESC Guidelines for the management of endocarditis.
|
Eur Heart J
37622656
|
42 |
39.3 |
2023 |
|
Interaction of heart failure and stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis.
|
Eur J Heart Fail
37905380
|
0 |
18.2 |
2023 |
|
The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
|
Eur J Heart Fail
36999379
|
3 |
18.2 |
2023 |
|
Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
|
Eur J Heart Fail
36781201
|
0 |
18.2 |
2023 |
|
Heart failure and the heart-brain axis.
|
QJM
37481714
|
1 |
13.3 |
2023 |
|
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial.
|
JACC Heart Fail
36881400
|
1 |
13 |
2023 |
|
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
|
J Cachexia Sarcopenia Muscle
38158636
|
1 |
8.9 |
2023 |
|
Obesity, metabolic health and clinical outcomes after incident cardiovascular disease: A nationwide population-based cohort study.
|
J Cachexia Sarcopenia Muscle
37806948
|
1 |
8.9 |
2023 |
|
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study.
|
Stroke Vasc Neurol
37353342
|
1 |
5.9 |
2023 |
|
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies.
|
Clin Res Cardiol
36884078
|
2 |
5 |
2023 |
|
Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation.
|
Sci Rep
36964268
|
0 |
4.6 |
2023 |
|
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments.
|
Curr Probl Cardiol
37040854
|
0 |
4.2 |
2023 |
|
Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure.
|
ESC Heart Fail
36907649
|
1 |
3.8 |
2023 |
|
[The polypill in cardiovascular prevention: successful through simplification? : New study results on the benefit of the polypill strategy in primary and secondary prevention].
|
Inn Med (Heidelb)
37227456
|
0 |
0.01 |
2023 |
|
Polypill Strategy in Secondary Cardiovascular Prevention.
|
N Engl J Med
36018037
|
29 |
158.5 |
2022 |
|
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
|
Eur Heart J
35788657
|
9 |
39.3 |
2022 |
|
Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.
|
Eur Heart J
35552401
|
4 |
39.3 |
2022 |
|
Sodium-glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction - lessons from clinical trials. Letter regarding the article 'Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF'.
|
Eur J Heart Fail
36036700
|
0 |
18.2 |
2022 |
|
Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced.
|
Eur J Heart Fail
36325584
|
4 |
18.2 |
2022 |
|
Iron deficiency is related to low functional outcome in patients at early rehabilitation after acute stroke.
|
J Cachexia Sarcopenia Muscle
35166066
|
6 |
8.9 |
2022 |
|
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology.
|
Eur J Prev Cardiol
36098041
|
10 |
8.3 |
2022 |
|
Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology.
|
Eur J Prev Cardiol
34077542
|
41 |
8.3 |
2022 |
|
Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
|
J Transl Med
35317812
|
48 |
7.4 |
2022 |
|
Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials.
|
Int J Stroke
35689348
|
0 |
6.7 |
2022 |
|
Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry.
|
J Neurol
34837502
|
0 |
6 |
2022 |
|
Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
|
J Clin Med
35683366
|
2 |
3.9 |
2022 |
|
Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke.
|
J Clin Med
35160047
|
2 |
3.9 |
2022 |
|
Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency.
|
ESC Heart Fail
36178088
|
4 |
3.8 |
2022 |
|
Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction-A Pilot Study.
|
J Cardiovasc Dev Dis
36547453
|
0 |
2.4 |
2022 |
|
ESC Working Group on e-Cardiology Position Paper: accuracy and reliability of electrocardiogram monitoring in the detection of atrial fibrillation in cryptogenic stroke patients: In collaboration with the Council on Stroke, the European Heart Rhythm Association, and the Digital Health Committee.
|
Eur Heart J Digit Health
36712155
|
3 |
0.01 |
2022 |
|
Cardiac Thrombogenicity in Stroke: Mechanisms and Evaluation.
|
Eur J Vasc Endovasc Surg
36309461
|
0 |
0 |
2022 |
|
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
|
Lancet Diabetes Endocrinol
34861154
|
7 |
44.5 |
2021 |
|
Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.
|
Circulation
34459213
|
65 |
39.918 |
2021 |
|
Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 — a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke [corrected].
|
Eur Heart J
33496325
|
2 |
35.855 |
2021 |
|
Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment. Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions with the support of the European Board of Neurointervention.
|
Eur Heart J
33521827
|
6 |
35.855 |
2021 |
|
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
|
Eur Heart J
34080008
|
29 |
35.855 |
2021 |
|
Obesity and long-term outcomes after incident stroke: a prospective population-based cohort study.
|
J Cachexia Sarcopenia Muscle
34581015
|
4 |
12.063 |
2021 |
|
Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.
|
Stroke
34078109
|
16 |
10.17 |
2021 |
|
Delphi consensus recommendations on how to provide cardiovascular rehabilitation in the COVID-19 era.
|
Eur J Prev Cardiol
33624042
|
9 |
8.526 |
2021 |
|
Beware of TOSCA's kiss or metabolic and hormonal aspects of heart failure.
|
Eur J Prev Cardiol
33778865
|
0 |
8.526 |
2021 |
|
Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS.
|
J Transl Med
33874961
|
16 |
8.44 |
2021 |
|
Expert opinion paper on cardiac imaging after ischemic stroke.
|
Clin Res Cardiol
34143285
|
4 |
6.138 |
2021 |
|
Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry.
|
J Neurol
34718884
|
2 |
6 |
2021 |
|
Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey.
|
Europace
34020460
|
1 |
5.486 |
2021 |
|
The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke.
|
Europace
33554259
|
3 |
5.486 |
2021 |
|
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.
|
J Clin Med
34072494
|
4 |
4.964 |
2021 |
|
Ischemic Stroke and Heart Failure: Facts and Numbers. An Update.
|
J Clin Med
33803423
|
4 |
4.964 |
2021 |
|
Proenkephalin A as Potential Prognostic Biomarker in Acute Ischemic Stroke.
|
Clin Appl Thromb Hemost
32731754
|
0 |
2.389 |
2021 |
|
Mental involvement in heart failure.
|
Rev Port Cardiol (Engl Ed)
34392897
|
0 |
0.01 |
2021 |
|
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
|
Circulation
33081531
|
73 |
39.918 |
2020 |
|
The obesity paradigm in cardiovascular disease: the need for differentiated weight management.
|
Eur Heart J
33141190
|
0 |
29.983 |
2020 |
|
Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial.
|
Eur Heart J
32402060
|
25 |
29.983 |
2020 |
|
Stroke patients need cardiologists.
|
Eur Heart J
32666095
|
0 |
29.983 |
2020 |
|
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
|
Eur Heart J
31504418
|
1706 |
29.983 |
2020 |
|
Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials.
|
Eur J Heart Fail
32392403
|
30 |
17.349 |
2020 |
|
Muscle wasting as an independent predictor of survival in patients with chronic heart failure.
|
J Cachexia Sarcopenia Muscle
32767518
|
40 |
12.91 |
2020 |
|
Comment on: "Handgrip weakness, low fat-free mass, and overall survival in nonsmall cell lung cancer treated with curative-intent radiotherapy" by Burtin et al.
|
J Cachexia Sarcopenia Muscle
33340290
|
2 |
12.91 |
2020 |
|
Comment on: "Experimental ischaemic stroke induces transient cardiac athrophy" by Veltkamp et al.
|
J Cachexia Sarcopenia Muscle
33340289
|
2 |
12.91 |
2020 |
|
MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia.
|
J Cachexia Sarcopenia Muscle
32067370
|
9 |
12.91 |
2020 |
|
Comment on 'Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes' by Niedziela et al.
|
J Cachexia Sarcopenia Muscle
33241893
|
2 |
12.91 |
2020 |
|
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
|
Lancet
33197395
|
146 |
9.153 |
2020 |
|
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology.
|
Eur J Prev Cardiol
33611446
|
162 |
8.526 |
2020 |
|
RNAs in Brain and Heart Diseases.
|
Int J Mol Sci
32466222
|
3 |
5.923 |
2020 |
|
Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome.
|
ESC Heart Fail
33121218
|
6 |
4.411 |
2020 |
|
Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies.
|
ESC Heart Fail
32860353
|
2 |
4.411 |
2020 |
|
Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
|
ESC Heart Fail
32154656
|
32 |
4.411 |
2020 |
|
Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis.
|
ESC Heart Fail
33586856
|
9 |
4.411 |
2020 |
|
The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT Study.
|
ESC Heart Fail
32189474
|
7 |
4.411 |
2020 |
|
Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls.
|
Nutr Metab Cardiovasc Dis
32682746
|
1 |
4.222 |
2020 |
|
The role of cardiologists on the stroke unit.
|
Eur Heart J Suppl
33664634
|
2 |
1.803 |
2020 |
|
Interdisciplinary stroke care in 2020: the need for cardiologists to learn about stroke.
|
Eur Heart J Suppl
33664633
|
0 |
1.803 |
2020 |
|
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
|
Circulation
31765261
|
65 |
23.603 |
2019 |
|
The evolving obesity paradigm story: from heart failure to atrial fibrillation.
|
Eur Heart J
31009055
|
0 |
22.673 |
2019 |
|
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
|
Eur Heart J
31541549
|
2 |
22.673 |
2019 |
|
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial.
|
Eur J Heart Fail
31584231
|
47 |
11.627 |
2019 |
|
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial.
|
Eur J Heart Fail
31523904
|
77 |
11.627 |
2019 |
|
Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure.
|
Eur J Heart Fail
31646718
|
66 |
11.627 |
2019 |
|
Intravenous iron supplementation is state of the art therapy in patients with heart failure and iron deficiency.
|
Eur J Heart Fail
31116486
|
1 |
11.627 |
2019 |
|
Cachexia as a common characteristic in multiple chronic disease.
|
J Cachexia Sarcopenia Muscle
30637985
|
23 |
10.754 |
2019 |
|
Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta-analysis.
|
J Cachexia Sarcopenia Muscle
30656860
|
20 |
9.802 |
2019 |
|
Body weight changes and incidence of cachexia after stroke.
|
J Cachexia Sarcopenia Muscle
30680953
|
17 |
9.802 |
2019 |
|
Sarcopenia: A Time for Action. An SCWD Position Paper.
|
J Cachexia Sarcopenia Muscle
31523937
|
174 |
9.802 |
2019 |
|
A tissue-specific screen of ceramide expression in aged mice identifies ceramide synthase-1 and ceramide synthase-5 as potential regulators of fiber size and strength in skeletal muscle.
|
Aging Cell
31692231
|
9 |
9.304 |
2019 |
|
Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table.
|
Eur J Prev Cardiol
31569966
|
7 |
7.804 |
2019 |
|
The importance of return to work: How to achieve optimal reintegration in ACS patients.
|
Eur J Prev Cardiol
30971111
|
8 |
5.864 |
2019 |
|
Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable.
|
Int J Mol Sci
31717934
|
13 |
4.556 |
2019 |
|
Severe Weight Loss and Its Association with Fatigue in Old Patients at Discharge from a Geriatric Hospital.
|
Nutrients
31658676
|
3 |
4.546 |
2019 |
|
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
|
Eur Heart J Cardiovasc Pharmacother
31119266
|
19 |
3.152 |
2019 |
|
Dementia and the heart failure patient.
|
Eur Heart J Suppl
31885510
|
7 |
1.655 |
2019 |
|
Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study.
|
Medicine (Baltimore)
30608424
|
0 |
1.552 |
2019 |
|
Smoking and Other Risk Factors in Type 2 Diabetes.
|
N Engl J Med
30586511
|
1 |
70.67 |
2018 |
|
Stroke-heart syndrome: clinical presentation and underlying mechanisms.
|
Lancet Neurol
30509695
|
55 |
28.755 |
2018 |
|
The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke.
|
Eur Heart J
29020357
|
6 |
23.239 |
2018 |
|
Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
Eur J Heart Fail
30160804
|
65 |
13.965 |
2018 |
|
Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice.
|
Eur J Heart Fail
30311713
|
40 |
13.965 |
2018 |
|
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
29520964
|
169 |
13.965 |
2018 |
|
Heart-brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity: reply.
|
Eur J Heart Fail
29656573
|
1 |
13.965 |
2018 |
|
Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation? Reply.
|
Eur J Heart Fail
30004161
|
2 |
13.965 |
2018 |
|
The Obesity Paradigm and Lifetime Risk of Cardiovascular Disease.
|
JAMA Cardiol
29998316
|
2 |
11.866 |
2018 |
|
The importance of rehabilitation in the secondary prevention of cardiovascular disease.
|
Eur J Prev Cardiol
30354743
|
2 |
5.864 |
2018 |
|
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
|
Clin Res Cardiol
30051186
|
33 |
5.268 |
2018 |
|
Expert opinion paper on atrial fibrillation detection after ischemic stroke.
|
Clin Res Cardiol
29704214
|
26 |
4.907 |
2018 |
|
High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke.
|
J Neurol
30311052
|
9 |
3.956 |
2018 |
|
Do we need a reference standard for the muscle mass measurements?
|
ESC Heart Fail
30270537
|
5 |
3.407 |
2018 |
|
Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
|
ESC Heart Fail
29476612
|
11 |
3.407 |
2018 |
|
Iron deficiency in chronic heart failure: case-based practical guidance.
|
ESC Heart Fail
30073785
|
24 |
3.407 |
2018 |
|
Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
|
PLoS One
29543914
|
44 |
2.9 |
2018 |
|
Comorbidities of chronic heart failure - a systemic syndrome requiring cross-specialty efforts.
|
J Cardiovasc Med (Hagerstown)
29389815
|
0 |
1.427 |
2018 |
|
[Iron deficiency in heart failure. A new diagnostic therapy algorithm - evidence-tested and workable].
|
MMW Fortschr Med
29974435
|
0 |
0.109 |
2018 |
|
Heart-brain Interactions in Heart Failure.
|
Card Fail Rev
30206482
|
16 |
0 |
2018 |
|
Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association.
|
Eur J Heart Fail
29280256
|
50 |
13.965 |
2017 |
|
Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
28560717
|
101 |
10.683 |
2017 |
|
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.
|
Am J Hematol
28612425
|
102 |
5.303 |
2017 |
|
Sleep-Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction.
|
J Am Heart Assoc
28893762
|
4 |
4.45 |
2017 |
|
Models of sarcopenia: Short review.
|
Int J Cardiol
28465116
|
19 |
4.034 |
2017 |
|
Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results.
|
Int J Cardiol
28476513
|
17 |
4.034 |
2017 |
|
Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
|
Int J Cardiol
28427849
|
26 |
4.034 |
2017 |
|
[Iron Deficiency in Chronic Heart Failure: Diagnostic Algorithm and Present-Day Therapeutic Options].
|
Dtsch Med Wochenschr
28303555
|
3 |
0.523 |
2017 |
|
Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany.
|
ESC Heart Fail
28772041
|
13 |
0 |
2017 |
|
Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
ESC Heart Fail
28960880
|
39 |
0 |
2017 |
|
Cardiac muscle wasting in individuals with cancer cachexia.
|
ESC Heart Fail
29154433
|
41 |
0 |
2017 |
|
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
|
N Engl J Med
27532847
|
0 |
72.406 |
2016 |
|
Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.
|
Eur Heart J
26865478
|
62 |
20.212 |
2016 |
|
Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
|
J Cachexia Sarcopenia Muscle
27239419
|
30 |
9.697 |
2016 |
|
Dysfunction of respiratory muscles in critically ill patients on the intensive care unit.
|
J Cachexia Sarcopenia Muscle
27030815
|
45 |
9.697 |
2016 |
|
Cardiac cachexia: hic et nunc.
|
J Cachexia Sarcopenia Muscle
27386168
|
51 |
9.697 |
2016 |
|
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
|
Eur J Heart Fail
26821594
|
99 |
6.968 |
2016 |
|
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
|
Int J Cardiol
27454614
|
87 |
6.189 |
2016 |
|
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
|
Int J Cardiol
27288971
|
1 |
6.189 |
2016 |
|
Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).
|
J Am Med Dir Assoc
27816483
|
27 |
5.325 |
2016 |
|
Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.
|
Resuscitation
27565863
|
4 |
5.23 |
2016 |
|
Transgenerational transmission of an anticholinergic endophenotype with memory dysfunction.
|
Neurobiol Aging
28033505
|
3 |
4.454 |
2016 |
|
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure.
|
J Hypertens
27488547
|
4 |
4.085 |
2016 |
|
Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
|
Int J Cardiol
28063669
|
3 |
4.034 |
2016 |
|
Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
Circ J
27904018
|
12 |
3.544 |
2016 |
|
Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.
|
J Endocrinol Invest
27738907
|
5 |
3.166 |
2016 |
|
The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.
|
COPD
26914392
|
51 |
2.576 |
2016 |
|
Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure?
|
Aging Male
27650467
|
4 |
2.108 |
2016 |
|
Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study).
|
BMC Neurol
26793971
|
4 |
2.006 |
2016 |
|
Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study.
|
Cardiorenal Med
27994602
|
1 |
1.844 |
2016 |
|
Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure.
|
Wien Klin Wochenschr
27853883
|
18 |
0.974 |
2016 |
|
Estimating fat mass in heart failure patients.
|
Arch Med Sci Atheroscler Dis
28905026
|
1 |
0 |
2016 |
|
Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'.
|
Eur Heart J
26341892
|
15 |
20.212 |
2015 |
|
Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance.
|
Diabetes Care
25538323
|
4 |
11.857 |
2015 |
|
The impact of body weight on mortality after stroke: the controversy continues.
|
JAMA Neurol
25581865
|
1 |
10.029 |
2015 |
|
Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation.
|
J Cachexia Sarcopenia Muscle
27066319
|
28 |
9.697 |
2015 |
|
Searching for a relevant definition of sarcopenia: results from the cross-sectional EPIDOS study.
|
J Cachexia Sarcopenia Muscle
27065221
|
7 |
9.697 |
2015 |
|
Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure.
|
J Cachexia Sarcopenia Muscle
26672973
|
10 |
9.697 |
2015 |
|
Febuxostat improves outcome in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
26136193
|
9 |
9.697 |
2015 |
|
Request for regulatory guidance for cancer cachexia intervention trials.
|
J Cachexia Sarcopenia Muscle
26675232
|
57 |
9.697 |
2015 |
|
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure.
|
JACC Heart Fail
25660838
|
127 |
8.493 |
2015 |
|
Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
|
Eur J Heart Fail
26198713
|
19 |
6.968 |
2015 |
|
Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
Eur J Heart Fail
26449626
|
23 |
6.968 |
2015 |
|
Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
|
Int J Cardiol
26318388
|
20 |
6.189 |
2015 |
|
Cardiac cachexia: hic et nunc: "hic et nunc" - here and now.
|
Int J Cardiol
26545926
|
10 |
6.189 |
2015 |
|
The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
|
Int J Cardiol
26705670
|
36 |
6.189 |
2015 |
|
Stroke-related sarcopenia: specific characteristics.
|
J Am Med Dir Assoc
25676847
|
51 |
5.775 |
2015 |
|
Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure.
|
J Mol Cell Cardiol
26264758
|
6 |
5.68 |
2015 |
|
Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis.
|
Atherosclerosis
26298741
|
52 |
4.239 |
2015 |
|
Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke--a retrospective analysis.
|
BMC Neurol
26349854
|
5 |
2.006 |
2015 |
|
Effects of dialysis modality on blood loss, bleeding complications and transfusion requirements in critically ill patients with dialysis-dependent acute renal failure.
|
Anaesth Intensive Care
26603802
|
5 |
1.695 |
2015 |
|
[Comments on the 2014 guidelines of the ESC/ESA: recommendations for the pre-operative assessment in non-cardiac surgery].
|
Dtsch Med Wochenschr
26069914
|
0 |
0.552 |
2015 |
|
[Diagnostic and treatment principles of iron deficiency anaemia].
|
MMW Fortschr Med
26985511
|
1 |
0.131 |
2015 |
|
Validation of the FEW16 questionnaire for the assessment of physical well-being in patients with heart failure with reduced ejection fraction: results from the CIBIS-ELD study.
|
ESC Heart Fail
27708856
|
2 |
0 |
2015 |
|
Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure.
|
ESC Heart Fail
28834658
|
17 |
0 |
2015 |
|
Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.
|
ESC Heart Fail
27774258
|
6 |
0 |
2015 |
|
Abnormal serum calcium levels are associated with clinical response to maximization of heart failure therapy.
|
Pol Arch Med Wewn
25578437
|
2 |
0 |
2015 |
|
Ischemic stroke and heart failure: facts and numbers.
|
ESC Heart Fail
28834645
|
8 |
0 |
2015 |
|
A direct link between haemodynamic failure and inflammatory activation in heart failure: the simplified approach to heart failure and to creation of life.
|
Eur Heart J
24408891
|
1 |
20.212 |
2014 |
|
How to determine a metabolically healthy body composition in cardiovascular disease.
|
J Am Coll Cardiol
25212653
|
0 |
19.896 |
2014 |
|
Metabolic impairment in heart failure: the myocardial and systemic perspective.
|
J Am Coll Cardiol
25257642
|
80 |
19.896 |
2014 |
|
Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia.
|
J Am Coll Cardiol
25212642
|
85 |
19.896 |
2014 |
|
Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer.
|
J Am Coll Cardiol
25257631
|
45 |
19.896 |
2014 |
|
Comment on Hinnouho et al. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes care 2013;36:2294-2300.
|
Diabetes Care
24757236
|
0 |
11.857 |
2014 |
|
Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies.
|
J Cachexia Sarcopenia Muscle
24595460
|
32 |
9.697 |
2014 |
|
I. Peripheral endothelial dysfunction after subarachnoid haemorrhage: what the fingertips can tell us.
|
Br J Anaesth
24431348
|
1 |
6.238 |
2014 |
|
Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy.
|
Int J Cardiol
25499388
|
2 |
6.189 |
2014 |
|
Bone marrow iron depletion is common in patients with coronary artery disease.
|
Int J Cardiol
25661858
|
14 |
6.189 |
2014 |
|
Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia.
|
Stroke
25352483
|
38 |
6.032 |
2014 |
|
Response to the letter to the editor from Xue and Varadhan titled "What is missing in the validation of frailty instruments?".
|
J Am Med Dir Assoc
24461247
|
0 |
5.775 |
2014 |
|
Critical appraisal of the obesity paradox in cardiovascular disease: how to manage patients with overweight in heart failure?
|
Heart Fail Rev
24554113
|
9 |
3.481 |
2014 |
|
Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival.
|
ESC Heart Fail
28834667
|
2 |
0 |
2014 |
|
Overweight, obesity, and all-cause mortality.
|
JAMA
23613063
|
2 |
44.405 |
2013 |
|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
|
Eur Heart J
23990596
|
88 |
20.212 |
2013 |
|
Iron status and survival in diabetic patients with coronary artery disease.
|
Diabetes Care
24130349
|
26 |
11.857 |
2013 |
|
Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS).
|
J Cachexia Sarcopenia Muscle
23483531
|
13 |
9.697 |
2013 |
|
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats.
|
J Cachexia Sarcopenia Muscle
24272787
|
25 |
9.697 |
2013 |
|
Increased catabolic activity in adipose tissue of patients with chronic heart failure.
|
Eur J Heart Fail
23696611
|
19 |
6.968 |
2013 |
|
Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research.
|
Eur J Heart Fail
24453095
|
1 |
6.968 |
2013 |
|
Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain.
|
CMAJ
23509133
|
5 |
6.784 |
2013 |
|
Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
|
Int J Cardiol
23680591
|
17 |
6.189 |
2013 |
|
Frailty and heart disease.
|
Int J Cardiol
23931976
|
20 |
6.189 |
2013 |
|
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy.
|
Int J Cardiol
23360823
|
25 |
6.189 |
2013 |
|
Cardiac cachexia is associated with right ventricular failure and liver dysfunction.
|
Int J Cardiol
24063924
|
16 |
6.189 |
2013 |
|
The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
|
Int J Cardiol
23751350
|
12 |
6.189 |
2013 |
|
Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure.
|
Int J Cardiol
24405838
|
6 |
6.189 |
2013 |
|
Stroke induced Sarcopenia: muscle wasting and disability after stroke.
|
Int J Cardiol
24231058
|
92 |
6.189 |
2013 |
|
Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
|
Int J Cardiol
24207070
|
8 |
6.189 |
2013 |
|
Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model.
|
Int J Cardiol
23465234
|
8 |
6.189 |
2013 |
|
Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).
|
J Am Med Dir Assoc
24094897
|
11 |
5.775 |
2013 |
|
Frailty consensus: a call to action.
|
J Am Med Dir Assoc
23764209
|
1066 |
5.775 |
2013 |
|
Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
|
Nutr Metab Cardiovasc Dis
23791298
|
31 |
3.679 |
2013 |
|
Muscle wasting in heart failure: An overview.
|
Int J Biochem Cell Biol
23665153
|
47 |
3.505 |
2013 |
|
Mechanism and novel therapeutic approaches to wasting in chronic disease.
|
Maturitas
23664695
|
21 |
3.255 |
2013 |
|
Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
|
Nutrition
24976415
|
6 |
3.099 |
2013 |
|
Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS): a protocol for a randomised controlled trial.
|
BMC Neurol
23347503
|
10 |
2.006 |
2013 |
|
Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study.
|
Arch Med Sci
23671436
|
5 |
1.969 |
2013 |
|
Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly?
|
Aging Male
23803163
|
1 |
1.85 |
2013 |
|
Andropausal syndrome in men with systolic heart failure.
|
Pol Arch Med Wewn
23449158
|
3 |
0 |
2013 |
|
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
|
Eur Heart J
23178647
|
196 |
20.212 |
2012 |
|
Diagnostic biomarkers in cardiovascular disease: the proteomics approach.
|
Eur Heart J
22766582
|
4 |
20.212 |
2012 |
|
Overweight and obesity are associated with improved survival, functional outcome, and stroke recurrence after acute stroke or transient ischaemic attack: observations from the TEMPiS trial.
|
Eur Heart J
23076781
|
74 |
20.212 |
2012 |
|
Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke.
|
J Am Coll Cardiol
22813614
|
17 |
19.896 |
2012 |
|
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
|
J Am Coll Cardiol
22300693
|
35 |
19.896 |
2012 |
|
Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
22460618
|
12 |
9.697 |
2012 |
|
The obesity paradox in chronic disease: facts and numbers.
|
J Cachexia Sarcopenia Muscle
22450395
|
49 |
9.697 |
2012 |
|
When a reference value makes all the difference.
|
J Cachexia Sarcopenia Muscle
22644800
|
0 |
9.697 |
2012 |
|
Erratum to: Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
22614821
|
0 |
9.697 |
2012 |
|
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
|
Int J Cancer
22336965
|
26 |
6.513 |
2012 |
|
Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
|
Int J Cardiol
22726401
|
3 |
6.189 |
2012 |
|
Anaemia predicts health related quality of life in heart failure patients.
|
Int J Cardiol
23127613
|
1 |
6.189 |
2012 |
|
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study.
|
Int J Cardiol
21856022
|
4 |
6.189 |
2012 |
|
Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease.
|
Int J Cardiol
22284271
|
18 |
6.189 |
2012 |
|
Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
|
Clin Sci (Lond)
22690794
|
2 |
4.936 |
2012 |
|
Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.
|
Clin Res Cardiol
22878732
|
3 |
4.76 |
2012 |
|
Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study.
|
Cephalalgia
22523187
|
12 |
3.609 |
2012 |
|
Insulin sensitivity, but not hyperglycemia, may be superior as a prognostic marker and therapeutic target for diabetes in heart failure.
|
Am J Cardiol
22964377
|
0 |
3.398 |
2012 |
|
Liver dysfunction and its nutritional implications in heart failure.
|
Nutrition
23022119
|
16 |
3.146 |
2012 |
|
[Anemia and iron deficiency in the elderly. Prevalence, diagnostics and new therapeutic options].
|
Z Gerontol Geriatr
22454095
|
6 |
0.885 |
2012 |
|
IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
21766056
|
25 |
9.697 |
2011 |
|
Sarcopenia in stroke-facts and numbers on muscle loss accounting for disability after stroke.
|
J Cachexia Sarcopenia Muscle
21475676
|
29 |
9.697 |
2011 |
|
Ursodeoxycholic acid treatment in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
22450540
|
12 |
9.697 |
2011 |
|
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.
|
J Cachexia Sarcopenia Muscle
21766053
|
49 |
9.697 |
2011 |
|
Cachexia in heart disease: highlights from the ESC 2010.
|
J Cachexia Sarcopenia Muscle
21475672
|
12 |
9.697 |
2011 |
|
Revisiting the obesity paradox in heart failure: new insights?
|
Eur J Heart Fail
21262928
|
2 |
6.968 |
2011 |
|
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.
|
Eur J Heart Fail
21429992
|
51 |
6.968 |
2011 |
|
Furosemide induces mortality in a rat model of chronic heart failure.
|
Int J Cardiol
21450356
|
5 |
6.189 |
2011 |
|
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.
|
Int J Cardiol
22037349
|
84 |
6.189 |
2011 |
|
Letter by Doehner et al regarding article, "Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox".
|
Stroke
21546473
|
0 |
6.032 |
2011 |
|
Body weight after stroke: lessons from the obesity paradox.
|
Stroke
21960580
|
52 |
6.032 |
2011 |
|
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1.
|
PLoS One
21264211
|
16 |
4.641 |
2011 |
|
Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.
|
J Card Fail
22041326
|
74 |
3.765 |
2011 |
|
Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.
|
Semin Nephrol
22000650
|
31 |
3.598 |
2011 |
|
Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease.
|
Respir Med
22015080
|
9 |
3.217 |
2011 |
|
Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke.
|
Cerebrovasc Dis
22133764
|
18 |
2.974 |
2011 |
|
Hormonal consequences and prognosis of chronic heart failure.
|
Curr Opin Endocrinol Diabetes Obes
21494135
|
11 |
0 |
2011 |
|
Systolic heart failure.
|
N Engl J Med
20414982
|
0 |
72.406 |
2010 |
|
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
J Cachexia Sarcopenia Muscle
21475696
|
29 |
9.697 |
2010 |
|
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol.
|
Clin Pharmacol Ther
20827268
|
13 |
7.266 |
2010 |
|
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
|
Eur J Heart Fail
20215339
|
43 |
6.968 |
2010 |
|
Absolute and functional iron deficiency in professional athletes during training and recovery.
|
Int J Cardiol
21145121
|
28 |
6.189 |
2010 |
|
The small intestine: a critical linkage in pathophysiology of cardiac cachexia.
|
Int J Cardiol
21112652
|
7 |
6.189 |
2010 |
|
Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.
|
Int J Cardiol
21190739
|
79 |
6.189 |
2010 |
|
Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters.
|
Int J Cardiol
21093941
|
7 |
6.189 |
2010 |
|
Nutritional recommendations for the management of sarcopenia.
|
J Am Med Dir Assoc
20627179
|
177 |
5.775 |
2010 |
|
Anaemia is an independent predictor of death in patients hospitalized for acute heart failure.
|
Clin Res Cardiol
19921298
|
18 |
4.76 |
2010 |
|
Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation.
|
J Mol Med (Berl)
20972769
|
18 |
4.686 |
2010 |
|
Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure.
|
Circ Heart Fail
20233990
|
9 |
4.315 |
2010 |
|
Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference.
|
Expert Opin Investig Drugs
20367196
|
20 |
4.03 |
2010 |
|
Losartan: the dose does it.
|
Expert Opin Pharmacother
20497092
|
0 |
3.894 |
2010 |
|
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
|
Am J Cardiol
20609652
|
15 |
3.398 |
2010 |
|
The obesity paradox: weighing the benefit.
|
Eur Heart J
19734553
|
40 |
20.212 |
2009 |
|
Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension.
|
Int J Cardiol
19411119
|
15 |
6.189 |
2009 |
|
Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure.
|
Int J Cardiol
19733925
|
10 |
6.189 |
2009 |
|
The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
|
Int J Cardiol
19155075
|
18 |
6.189 |
2009 |
|
Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients.
|
Am J Transplant
19845589
|
10 |
6.165 |
2009 |
|
Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.
|
PLoS One
19641622
|
14 |
4.687 |
2009 |
|
Exercise capacity and body composition in living-donor renal transplant recipients over time.
|
Nephrol Dial Transplant
19736242
|
11 |
4.47 |
2009 |
|
Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
|
Circ Heart Fail
19933411
|
59 |
4.315 |
2009 |
|
Nutrition in heart failure: an update.
|
Curr Opin Clin Nutr Metab Care
19474718
|
16 |
4.023 |
2009 |
|
Overview of emerging pharmacotherapy in chronic heart failure.
|
Expert Opin Pharmacother
19606938
|
0 |
3.894 |
2009 |
|
The influence of recovery and training phases on body composition, peripheral vascular function and immune system of professional soccer players.
|
PLoS One
19293937
|
19 |
2.806 |
2009 |
|
Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.
|
Heart Fail Clin
19631179
|
36 |
2.124 |
2009 |
|
The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.
|
Wien Klin Wochenschr
19562292
|
23 |
0.974 |
2009 |
|
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.
|
Wien Klin Wochenschr
19562289
|
11 |
0.974 |
2009 |
|
Insulin resistance in chronic heart failure.
|
J Am Coll Cardiol
18617075
|
6 |
19.896 |
2008 |
|
Uric acid in chronic heart failure--current pathophysiological concepts.
|
Eur J Heart Fail
19008148
|
2 |
6.968 |
2008 |
|
Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
|
Int J Cardiol
18778861
|
15 |
6.189 |
2008 |
|
Weight change with beta-blocker use: a side effect put into perspective.
|
Am J Med
18456014
|
0 |
5.55 |
2008 |
|
Beta blockers and glucose metabolism in chronic heart failure: friend or foe?
|
Clin Res Cardiol
18026703
|
4 |
4.76 |
2008 |
|
Differentiating between body fat and lean mass--how should we measure obesity?
|
Nat Clin Pract Endocrinol Metab
18946485
|
4 |
0 |
2008 |
|
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
|
Eur Heart J
17353227
|
42 |
20.212 |
2007 |
|
Altered intestinal function in patients with chronic heart failure.
|
J Am Coll Cardiol
17936155
|
199 |
19.896 |
2007 |
|
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
|
J Am Coll Cardiol
17996563
|
42 |
19.896 |
2007 |
|
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
|
J Am Coll Cardiol
17825714
|
181 |
19.896 |
2007 |
|
Uric acid as a prognostic marker in acute heart failure--new expectations from an old molecule.
|
Eur J Heart Fail
17433888
|
4 |
6.968 |
2007 |
|
Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
|
Eur J Pharmacol
17669395
|
12 |
2.896 |
2007 |
|
World Congress of Cardiology 2006. Barcelona, Spain, September 2-5, 2006.
|
Heart Fail Monit
17487297
|
0 |
0 |
2007 |
|
Questions in cardiac resynchronization therapy: metabolic implications.
|
J Am Coll Cardiol
16875992
|
0 |
19.896 |
2006 |
|
Obesity and the heart a weighty issue.
|
J Am Coll Cardiol
16750695
|
5 |
19.896 |
2006 |
|
Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!
|
Eur J Heart Fail
17027336
|
6 |
6.968 |
2006 |
|
Survival and body fat in hemodialysis patients: true association or effects of concomitant therapy?
|
Am J Clin Nutr
16960183
|
0 |
6.926 |
2006 |
|
Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
|
Int J Cardiol
17064790
|
30 |
6.189 |
2006 |
|
Uric acid in CHF: marker or player in a metabolic disease?
|
Int J Cardiol
16844250
|
4 |
6.189 |
2006 |
|
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
|
Cardiovasc Res
17034772
|
68 |
5.878 |
2006 |
|
The roles of immunity and autoimmunity in chronic heart failure.
|
Ernst Schering Res Found Workshop
16329662
|
0 |
0 |
2006 |
|
Heart failure therapy: testosterone replacement and its implications.
|
Eur Heart J
16291772
|
0 |
20.212 |
2005 |
|
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
|
J Am Coll Cardiol
16168285
|
89 |
19.896 |
2005 |
|
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins.
|
Eur J Heart Fail
15921783
|
12 |
6.968 |
2005 |
|
Cellular endotoxin desensitization in patients with severe chronic heart failure.
|
Eur J Heart Fail
16087139
|
5 |
6.968 |
2005 |
|
Anemia and inflammation in COPD.
|
Chest
15764763
|
33 |
6.147 |
2005 |
|
Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
|
Heart
15894755
|
16 |
6.059 |
2005 |
|
Uric acid in chronic heart failure.
|
Semin Nephrol
15660337
|
12 |
3.598 |
2005 |
|
Association of deranged adrenal steroid metabolism with anemia in chronic heart failure.
|
Am J Cardiol
15979444
|
5 |
3.398 |
2005 |
|
Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure.
|
Horm Metab Res
15778928
|
3 |
2.268 |
2005 |
|
Anemia in chronic heart failure--clinical and prognostic significance.
|
Curr Med Chem Cardiovasc Hematol Agents
16250861
|
0 |
0 |
2005 |
|
Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
|
Int J Cardiol
15301893
|
32 |
6.189 |
2004 |
|
Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study.
|
Int J Cardiol
15336800
|
11 |
6.189 |
2004 |
|
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue.
|
J Card Fail
15470653
|
15 |
3.765 |
2004 |
|
The relationship between cholesterol and survival in patients with chronic heart failure.
|
J Am Coll Cardiol
14662255
|
105 |
19.896 |
2003 |
|
Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
|
Circulation
12707250
|
143 |
19.309 |
2003 |
|
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.
|
Int J Cardiol
12957752
|
7 |
6.189 |
2003 |
|
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
|
J Card Fail
12612870
|
63 |
3.765 |
2003 |
|
Anemia in chronic heart failure--frequency and prognostic impact.
|
Clin Nephrol
12940540
|
0 |
1.058 |
2003 |
|
The European Society of Cardiology XXIV Annual Congress 2002. Berlin, Germany, 31 August-4 September, 2002.
|
Heart Fail Monit
12647741
|
0 |
0 |
2003 |
|
Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
|
Circulation
12045167
|
174 |
19.309 |
2002 |
|
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.
|
Int J Cardiol
11959387
|
14 |
6.189 |
2002 |
|
Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration.
|
Int J Cardiol
12419560
|
19 |
6.189 |
2002 |
|
Cardiac cachexia in early literature: a review of research prior to Medline.
|
Int J Cardiol
12163205
|
12 |
6.189 |
2002 |
|
PRESTO (a mammoth trial that could have been prevented), HPS and REMATCH.
|
Int J Cardiol
12007680
|
0 |
6.189 |
2002 |
|
The cardiac component of cardiac cachexia.
|
Am Heart J
12094187
|
11 |
4.436 |
2002 |
|
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.
|
Am J Cardiol
12161227
|
16 |
3.398 |
2002 |
|
Meeting report from the 74th annual scientific sessions of the American Heart Association (AHA). Anaheim, CA, USA, November 11-14, 2001.
|
Heart Fail Monit
12638577
|
0 |
0 |
2002 |
|
Insulin-like growth factor-I can be helpful towards end of life.
|
BMJ
11291651
|
0 |
20.785 |
2001 |
|
Vascular effect of insulin in endothelial dysfunction.
|
J Am Coll Cardiol
11216999
|
0 |
19.896 |
2001 |
|
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone.
|
J Am Coll Cardiol
11499736
|
38 |
19.896 |
2001 |
|
Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure.
|
Circulation
11479251
|
98 |
19.309 |
2001 |
|
Wasting as an independent predictor of mortality in patients with cystic fibrosis.
|
Thorax
11562511
|
60 |
8.272 |
2001 |
|
The significance of leptin in human--do we know it yet?
|
Int J Cardiol
11104866
|
0 |
6.189 |
2001 |
|
Chronic heart failure in the very elderly: clinical status, survival, and prognostic factors in 188 patients more than 70 years old.
|
Am Heart J
11431675
|
10 |
4.436 |
2001 |
|
Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
|
Am Heart J
11320368
|
15 |
4.436 |
2001 |
|
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
|
Eur J Endocrinol
11720897
|
26 |
4.101 |
2001 |
|
High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients.
|
Cytokine
11500083
|
21 |
3.488 |
2001 |
|
TNF-alpha system in CHF.
|
Eur Heart J
10739736
|
0 |
20.212 |
2000 |
|
Plasma cytokine parameters and mortality in patients with chronic heart failure.
|
Circulation
11120695
|
201 |
19.309 |
2000 |
|
Defects in insulin action in chronic heart failure.
|
Diabetes Obes Metab
11225653
|
1 |
6.715 |
2000 |
|
Insulin-mediated glucose uptake in congestive heart failure.
|
Am J Cardiol
11078259
|
0 |
3.398 |
2000 |
|
Echocardiographic determinants of mortality in patients >67 years of age with chronic heart failure.
|
Am J Cardiol
10913476
|
3 |
3.398 |
2000 |
|
Cytoprotection in acute myocardial infarction.
|
Int J Cardiol
10636625
|
0 |
6.189 |
1999 |
|
Insulin-mediated glucose uptake in congestive heart failure.
|
Am J Cardiol
10498157
|
0 |
3.398 |
1999 |
